Trichostatin A prevents neointimal hyperplasia via activation of Krüppel like factor 4

Hae Jin Kee1, Jin-Sook Kwon, Sera Shin

  • 1Department of Pharmacology and Medical Research Center for Gene Regulation, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea. sshjkee@empas.com

Vascular Pharmacology
|July 19, 2011
PubMed

Insights

Trichostatin A (TSA) prevents vascular smooth muscle cell (VSMC) proliferation and neointimal hyperplasia by activating the Krüppel like factor 4 (KLF4)/p21/p27 pathway. This finding offers a potential therapeutic strategy for vascular diseases like restenosis.

Area of Science:

  • Vascular Biology
  • Molecular Medicine
  • Pharmacology

Background:

  • Vascular smooth muscle cell (VSMC) proliferation is central to vascular diseases such as restenosis.
  • Histone deacetylase (HDAC) inhibitors regulate gene expression and cell cycle arrest, but the specific role of trichostatin A (TSA) in neointimal proliferation is unclear.

Purpose of the Study:

  • To investigate the effect and mechanism of TSA in preventing VSMC proliferation and neointimal hyperplasia.
  • To elucidate the role of Krüppel like factor 4 (KLF4) in TSA-mediated inhibition of VSMC proliferation.

Main Methods:

  • Balloon injury model in rat carotid artery with local TSA administration.
  • In vitro VSMC proliferation assays (MTT, [³H]thymidine incorporation) with TSA, FBS, PDGF-BB.
  • KLF4 overexpression and knockdown experiments.
  • Analysis of KLF4, p21, and p27 mRNA and protein expression, and promoter activity.

Main Results:

  • Local TSA administration significantly reduced neointimal hyperplasia in vivo.
  • TSA inhibited VSMC proliferation and DNA synthesis in response to growth factors.
  • KLF4 overexpression suppressed VSMC proliferation, while KLF4 knockdown increased it.
  • TSA treatment increased KLF4 expression, which in turn upregulated p21 and p27 expression and promoter activity.
  • The anti-proliferative effect of TSA was dependent on KLF4.

Conclusions:

  • TSA effectively inhibits neointimal thickening and VSMC proliferation.
  • TSA exerts its anti-proliferative effects through the KLF4/p21/p27 signaling pathway.
  • This pathway represents a potential therapeutic target for managing vascular proliferative diseases.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...